The molecular pharmacology of glucagon agonists in diabetes and obesity.


Journal

Peptides
ISSN: 1873-5169
Titre abrégé: Peptides
Pays: United States
ID NLM: 8008690

Informations de publication

Date de publication:
07 2023
Historique:
received: 05 02 2023
revised: 20 03 2023
accepted: 21 03 2023
medline: 31 5 2023
pubmed: 31 3 2023
entrez: 30 3 2023
Statut: ppublish

Résumé

Within recent decades glucagon receptor (GcgR) agonism has drawn attention as a therapeutic tool for the treatment of type 2 diabetes and obesity. In both mice and humans, glucagon administration enhances energy expenditure and suppresses food intake suggesting a promising metabolic utility. Therefore synthetic optimization of glucagon-based pharmacology to further resolve the physiological and cellular underpinnings mediating these effects has advanced. Chemical modifications to the glucagon sequence have allowed for greater peptide solubility, stability, circulating half-life, and understanding of the structure-function potential behind partial and "super"-agonists. The knowledge gained from such modifications has provided a basis for the development of long-acting glucagon analogues, chimeric unimolecular dual- and tri-agonists, and novel strategies for nuclear hormone targeting into glucagon receptor-expressing tissues. In this review, we summarize the developments leading toward the current advanced state of glucagon-based pharmacology, while highlighting the associated biological and therapeutic effects in the context of diabetes and obesity.

Identifiants

pubmed: 36997003
pii: S0196-9781(23)00065-7
doi: 10.1016/j.peptides.2023.171003
pmc: PMC10265134
pii:
doi:

Substances chimiques

Glucagon 9007-92-5
Glucagon-Like Peptide 1 89750-14-1
Receptors, Glucagon 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

171003

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Références

PLoS One. 2015 Jul 29;10(7):e0132884
pubmed: 26222156
Proc Natl Acad Sci U S A. 1968 Oct;61(2):504-8
pubmed: 4300988
J Biol Chem. 1957 Jan;224(1):463-75
pubmed: 13398422
Diabetes. 2011 Feb;60(2):391-7
pubmed: 21270251
Cell Mol Life Sci. 2008 Jun;65(12):1880-99
pubmed: 18292967
Nature. 1981 Feb 5;289(5797):514-6
pubmed: 7007887
Eur J Clin Pharmacol. 1993;45(6):555-8
pubmed: 8157042
Diabetes. 1966 Mar;15(3):188-93
pubmed: 5909499
Endocrinology. 2018 Aug 1;159(8):3105-3119
pubmed: 29992313
Lancet. 1970 Nov 7;2(7680):946-9
pubmed: 4097595
EClinicalMedicine. 2021 Aug 13;39:101088
pubmed: 34430840
Mol Metab. 2021 Nov;53:101296
pubmed: 34271220
Mol Biol Cell. 2022 Sep 1;33(10):ar90
pubmed: 35767325
Am J Physiol Endocrinol Metab. 2021 Oct 1;321(4):E575-E578
pubmed: 34280050
Mol Metab. 2022 Sep;63:101530
pubmed: 35718339
Thyroid. 1994 Fall;4(3):319-26
pubmed: 7833670
Biochem J. 1978 Mar 15;170(3):615-25
pubmed: 206263
Am J Physiol. 1990 Nov;259(5 Pt 1):G736-44
pubmed: 2173415
J Biol Chem. 2016 Apr 22;291(17):8969-77
pubmed: 26984408
Int J Obes (Lond). 2013 Oct;37(10):1391-8
pubmed: 23337772
Annu Rev Physiol. 2022 Feb 10;84:17-40
pubmed: 34705480
Rev Diabet Stud. 2011 Fall;8(3):369-81
pubmed: 22262074
Nat Chem Biol. 2014 Dec;10(12):1061-5
pubmed: 25362359
Int J Mol Sci. 2019 Oct 30;20(21):
pubmed: 31671603
Cell Metab. 2016 Jul 12;24(1):51-62
pubmed: 27411008
Nat Med. 2015 Jan;21(1):27-36
pubmed: 25485909
JCI Insight. 2021 Feb 22;6(4):
pubmed: 33411693
Biochem Pharmacol. 2020 Oct;180:114150
pubmed: 32682761
J Clin Endocrinol Metab. 2020 Mar 1;105(3):
pubmed: 31608926
JCI Insight. 2019 Jul 23;5:
pubmed: 31335319
Endocrinology. 2015 Aug;156(8):2781-94
pubmed: 26020795
Endocrinology. 2004 Jun;145(6):2687-95
pubmed: 15001546
Diabetes. 2017 Feb;66(2):235-240
pubmed: 28108603
Sci Rep. 2020 Oct 7;10(1):16758
pubmed: 33028880
Int J Mol Sci. 2019 Aug 11;20(16):
pubmed: 31405212
Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1662-6
pubmed: 8383321
Mol Metab. 2018 Dec;18:3-14
pubmed: 30473097
Trends Pharmacol Sci. 2005 May;26(5):244-51
pubmed: 15860371
Expert Opin Ther Pat. 2020 Jul;30(7):509-526
pubmed: 32552241
Cardiovasc Diabetol. 2018 Nov 27;17(1):148
pubmed: 30482191
Regul Pept. 1988 May;21(1-2):117-28
pubmed: 2839870
Diabetes. 2017 Jan;66(1):36-44
pubmed: 27999106
J Biol Chem. 1955 Jun;214(2):619-32
pubmed: 14381399
Diabetes Care. 2021 Jun;44(6):1433-1442
pubmed: 34016612
Peptides. 1986;7 Suppl 1:69-74
pubmed: 3748851
Peptides. 2020 Mar;125:170225
pubmed: 31786282
J Appl Physiol. 1957 Nov;11(3):419-21
pubmed: 13480952
Cell Rep Med. 2022 Nov 15;3(11):100810
pubmed: 36384093
Biochemistry. 1975 Apr 22;14(8):1559-63
pubmed: 164891
Nat Commun. 2022 Feb 25;13(1):1057
pubmed: 35217653
Acta Pharm Sin B. 2022 Feb;12(2):637-650
pubmed: 35256936
PLoS Biol. 2009 Aug;7(8):e1000172
pubmed: 19688034
Lancet. 2018 Jun 30;391(10140):2607-2618
pubmed: 29945727
Biochem Z. 1965 Nov 5;343(1):107-10
pubmed: 5874983
Diabetes Obes Metab. 2019 Jan;21(1):120-128
pubmed: 30091218
Nature. 1986 Sep 4-10;323(6083):68-71
pubmed: 3018586
Endocrinology. 2017 Aug 1;158(8):2680-2693
pubmed: 28586439
J Diabetes Sci Technol. 2010 Nov 01;4(6):1322-31
pubmed: 21129326
Diabetes Care. 2016 Jul;39(7):1241-9
pubmed: 26681715
Physiol Rep. 2022 May;10(9):e15263
pubmed: 35569125
Diabetes Care. 2002 Aug;25(8):1398-404
pubmed: 12145241
Lancet. 2022 Nov 26;400(10366):1826-1828
pubmed: 36436519
Cell Metab. 2021 Apr 6;33(4):833-844.e5
pubmed: 33571454
Front Endocrinol (Lausanne). 2021 Sep 08;12:735019
pubmed: 34566894
Diabetes. 2014 Nov;63(11):3711-20
pubmed: 24939425
J Clin Invest. 2017 Aug 1;127(8):2941-2945
pubmed: 28650340
J Biol Chem. 1973 Aug 10;248(15):5344-9
pubmed: 4768903
Diabetes Obes Metab. 2020 Apr;22(4):640-647
pubmed: 31808298
Regul Pept. 1988 May;21(1-2):151-66
pubmed: 2839871
Br J Pharmacol. 2003 Mar;138(5):787-94
pubmed: 12642379
J Endocrinol. 2019 Nov;243(2):149-160
pubmed: 31454790
J Biol Chem. 2021 Jan-Jun;296:100133
pubmed: 33268378
Obesity (Silver Spring). 2012 Aug;20(8):1566-71
pubmed: 22421924
J Clin Endocrinol Metab. 2018 May 1;103(5):1804-1812
pubmed: 29546411
J Biol Chem. 1968 Aug 25;243(16):4189-96
pubmed: 5679958
J Biol Chem. 1984 Jul 10;259(13):8151-5
pubmed: 6330102
Sci Transl Med. 2013 Oct 30;5(209):209ra151
pubmed: 24174327
Thyroid. 2019 Sep;29(9):1173-1191
pubmed: 31389309
Clin Obes. 2021 Apr;11(2):e12432
pubmed: 33475255
Lancet. 1965 Aug 28;2(7409):415-6
pubmed: 14346763
Science. 1982 Feb 26;215(4536):1115-6
pubmed: 6278587
Front Endocrinol (Lausanne). 2021 May 18;12:689678
pubmed: 34093449
Chem Rev. 2018 Dec 12;118(23):11259-11297
pubmed: 30362705
J Clin Pharmacol. 2015 Mar;55(3):298-306
pubmed: 25197025
Diabetes Obes Metab. 2016 Dec;18(12):1176-1190
pubmed: 27377054
Curr Opin Mol Ther. 2000 Apr;2(2):162-7
pubmed: 11249637
Br J Pharmacol. 2022 Jul;179(14):3651-3674
pubmed: 35106752
Mol Metab. 2014 Nov 29;4(2):132-43
pubmed: 25685700
Endocr Rev. 2007 Feb;28(1):84-116
pubmed: 17261637
Nat Commun. 2022 Jun 24;13(1):3613
pubmed: 35750681
J Clin Endocrinol Metab. 1987 Jan;64(1):106-10
pubmed: 3536980
Endocrinology. 1954 Mar;54(3):303-10
pubmed: 13151124
Physiol Behav. 1984 Sep;33(3):397-400
pubmed: 6514829
Am J Physiol Regul Integr Comp Physiol. 2007 Feb;292(2):R962-70
pubmed: 17038440
Cardiovasc Diabetol. 2022 Sep 1;21(1):169
pubmed: 36050763
Physiol Rev. 2017 Apr;97(2):721-766
pubmed: 28275047
Am J Physiol Endocrinol Metab. 2009 Mar;296(3):E415-21
pubmed: 19116373
Cell. 2016 Oct 20;167(3):843-857.e14
pubmed: 27720451
Am J Physiol Gastrointest Liver Physiol. 2020 May 1;318(5):G912-G927
pubmed: 32174131
J Biol Chem. 2003 Jan 31;278(5):3293-7
pubmed: 12446722
Diabetes. 2005 Aug;54(8):2390-5
pubmed: 16046306
Diabetes Res Clin Pract. 2014 Jan;103(1):1-10
pubmed: 24367972
Diabetes Obes Metab. 2015 Apr;17(4):414-22
pubmed: 25656305
ACS Med Chem Lett. 2022 Jul 21;13(8):1248-1254
pubmed: 35978682
Nat Metab. 2020 Feb;2(2):192-209
pubmed: 32694693
J Clin Invest. 1956 Jul;35(7):757-62
pubmed: 13332058
J Intern Med. 2018 Dec;284(6):581-602
pubmed: 30230640
J Nutr. 2002 Aug;132(8):2174-82
pubmed: 12163658
J Med Chem. 2021 Apr 22;64(8):4697-4708
pubmed: 33821647
Clin Obes. 2021 Apr;11(2):e12433
pubmed: 33475251
EClinicalMedicine. 2022 Oct 07;54:101691
pubmed: 36247927
Am J Physiol Endocrinol Metab. 2002 Dec;283(6):E1173-7
pubmed: 12388165
Am J Physiol Endocrinol Metab. 2021 Oct 1;321(4):E571-E574
pubmed: 34369821
J Diabetes Sci Technol. 2018 Jul;12(4):847-853
pubmed: 29415555
Sci Rep. 2022 Oct 6;12(1):16765
pubmed: 36202918
Am J Physiol. 1992 Jun;262(6 Pt 2):R975-80
pubmed: 1621876
Diabetes. 2009 Oct;58(10):2258-66
pubmed: 19602537
Int J Mol Sci. 2019 Jul 05;20(13):
pubmed: 31284506
J Clin Invest. 1957 Jan;36(1 Part 1):74-80
pubmed: 13398485
Diabetes. 2013 Apr;62(4):1131-8
pubmed: 23248172
Cell Metab. 2022 Jan 4;34(1):59-74.e10
pubmed: 34932984
Cell Metab. 2022 Sep 6;34(9):1234-1247.e9
pubmed: 35985340
J Med Chem. 1984 Mar;27(3):310-5
pubmed: 6699876
Biochim Biophys Acta. 1993 Aug 7;1164(3):252-60
pubmed: 8102071
Sports Med. 2021 Sep;51(9):1949-1966
pubmed: 33905087
Neurosci Biobehav Rev. 1990 Fall;14(3):323-38
pubmed: 2234610
Diabetes Obes Metab. 2023 Apr;25(4):1011-1023
pubmed: 36527386
J Clin Endocrinol Metab. 2003 Oct;88(10):4696-701
pubmed: 14557443
Diabetes. 1957 May-Jun;6(3):234-8
pubmed: 13427628
Peptides. 2018 Jun;104:70-77
pubmed: 29680267
Sci Rep. 2021 Nov 19;11(1):22577
pubmed: 34799628
Endocrinology. 1992 Jul;131(1):447-57
pubmed: 1319325
Regul Pept. 2001 Jan 12;96(3):133-41
pubmed: 11111019
J Biol Chem. 2015 Sep 18;290(38):23009-22
pubmed: 26198634
Diabetes. 2018 Nov;67(11):2157-2166
pubmed: 30150304
Heart Fail Rev. 2010 Mar;15(2):125-32
pubmed: 19125327
Drug Metab Dispos. 2019 Oct;47(10):1100-1110
pubmed: 31043438
J Med Chem. 1997 Aug 1;40(16):2555-62
pubmed: 9258362
Mol Metab. 2021 Sep;51:101242
pubmed: 33933675
Cell Rep. 2018 Oct 30;25(5):1127-1134.e2
pubmed: 30380405
Proc Natl Acad Sci U S A. 1987 Jun;84(12):4083-7
pubmed: 3035568
Science. 1993 Mar 12;259(5101):1614-6
pubmed: 8384375
Proc Natl Acad Sci U S A. 1977 Aug;74(8):3340-4
pubmed: 269394
Nat Chem Biol. 2009 Oct;5(10):749-57
pubmed: 19597507
Nature. 2013 Feb 14;494(7436):256-60
pubmed: 23292513
J Lipid Res. 2015 Nov;56(11):2183-95
pubmed: 26373568
Eur J Biochem. 1972 Dec 18;31(3):505-9
pubmed: 4650155
Nat Rev Endocrinol. 2014 Apr;10(4):206-14
pubmed: 24322650
Diabetologia. 2017 Oct;60(10):1851-1861
pubmed: 28733905
Nat Commun. 2016 Mar 08;7:10856
pubmed: 26952277
Oxid Med Cell Longev. 2020 Jan 3;2020:6210526
pubmed: 31976031
FEBS Lett. 1982 Sep 6;146(1):73-8
pubmed: 7140976
Nat Commun. 2018 Apr 23;9(1):1602
pubmed: 29686402
Physiol Rev. 2014 Apr;94(2):355-82
pubmed: 24692351
Diabetes. 1990 Nov;39(11):1381-90
pubmed: 2121568
Nat Metab. 2021 Mar;3(3):394-409
pubmed: 33758419
Sci Rep. 2015 May 13;5:10211
pubmed: 25970118
Sci Signal. 2020 Mar 31;13(625):
pubmed: 32234959
Nature. 2020 Mar;579(7798):279-283
pubmed: 32132708
Diabetologia. 2001 Nov;44(11):2018-24
pubmed: 11719833
Front Physiol. 2019 Apr 24;10:413
pubmed: 31068828
Sci Adv. 2019 Sep 18;5(9):eaaw2778
pubmed: 31555726
Pharm Res. 2004 Jul;21(7):1274-83
pubmed: 15290870
Am J Physiol. 1993 Jan;264(1 Pt 2):R116-22
pubmed: 8430871
Peptides. 2021 Jan;135:170434
pubmed: 33172827
Diabetes. 2020 Apr;69(4):532-541
pubmed: 31178432
Curr Trends Endocinol. 2012 Jan 1;6:65-76
pubmed: 24436572
Lancet. 2022 Nov 26;400(10366):1869-1881
pubmed: 36354040
Br J Clin Pharmacol. 2018 Oct;84(10):2325-2335
pubmed: 29926478
J Med Chem. 2017 May 25;60(10):4293-4303
pubmed: 28448133
Diabetes. 2013 May;62(5):1453-63
pubmed: 23305646
Trends Pharmacol Sci. 2018 Feb;39(2):109-122
pubmed: 29157577
Nat Med. 2012 Dec;18(12):1847-56
pubmed: 23142820
Int J Obes Relat Metab Disord. 2000 Jun;24 Suppl 2:S109-12
pubmed: 10997623
Diabetes. 2020 Jun;69(6):1090-1099
pubmed: 31974144
Science. 2020 Mar 20;367(6484):1346-1352
pubmed: 32193322
Biochim Biophys Acta. 1984 Aug 17;804(4):434-41
pubmed: 6087925
Diabetologia. 2014 Sep;57(9):1927-36
pubmed: 24962667
J Recept Signal Transduct Res. 2009 Dec;29(6):318-25
pubmed: 19903011
PLoS Biol. 2019 Aug 20;17(8):e3000097
pubmed: 31430273
Cell Metab. 2022 Nov 1;34(11):1824-1842.e9
pubmed: 36243006
Pharmacol Rev. 2023 Jan;75(1):1-34
pubmed: 36757898
Diabetes. 2018 Sep;67(9):1773-1782
pubmed: 29925501
Nat Commun. 2020 Apr 20;11(1):1896
pubmed: 32312960
Mol Metab. 2021 Feb;44:101138
pubmed: 33285302
Mol Metab. 2019 Apr;22:37-48
pubmed: 30772257
C R Seances Acad Sci III. 1981 Oct 19;293(6):323-8
pubmed: 6797684

Auteurs

Aaron Novikoff (A)

Institute of Diabetes and Obesity, Helmholtz Center Munich, Neuherberg, Germany; German Center for Diabetes Research (DZD), Neuherberg, Germany. Electronic address: aaron.novikoff@helmholtz-munich.de.

Timo D Müller (TD)

Institute of Diabetes and Obesity, Helmholtz Center Munich, Neuherberg, Germany; German Center for Diabetes Research (DZD), Neuherberg, Germany. Electronic address: timodirk.muller@helmholtz-munich.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH